News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Razelle Kurzrock: Target Cancer National Molecular Tumor Board
Razelle Kurzrock/froedtert.com
Jan 26, 2025, 21:55

Razelle Kurzrock: Target Cancer National Molecular Tumor Board

Razelle Kurzrock, Founding Director at Michels Rare Cancers Research Laboratories shared a post on X:

“Target Cancer National Molecular Tumor Board. Bringing together experts across the country for the TRACK national precision medicine trial for rare cancers.

Thank you to an incredible group who give their time to help find solutions for patients with rare cancers.”

Razelle Kurzrock

More posts featuring Razelle Kurzrock.

 

cancer Cancer National Molecular Tumor Board medicine OncoDaily Oncology Razelle Kurzrock Trial tumor
Special Coverage
Voices
Aug 10, 2025, 15:36
Wafaa M Rashed: Africa for Africans - Shaping the Future of Genomics Policy
Career
Aug 10, 2025, 15:36
Bogda Koczwara: Join the Team of Australian Research Centre for Cancer Survivorship
Voices
Aug 10, 2025, 15:26
Sendurai Mani: Joining the Partnership to Reduce Cancer in Rhode Island Membership Meeting
Career
Aug 10, 2025, 15:00
Santosh Rao Joined to the HemOnc Department at Cleveland Clinic Akron General as the Medical Director
Science
Aug 10, 2025, 14:54
Monika J Dziuba: The Role of Organoids in Precision Medicine
Voices
Aug 10, 2025, 14:50
The Future of Pharmaceutical Infrastructure and Equitable Access to Medicines - Hikma Pharmaceuticals
Voices
Aug 10, 2025, 14:31
Anju Aledia: Celebrating Strength, Unity, and Hope Among Children Fighting Cancer
Voices
Aug 10, 2025, 14:19
Harish Nagaraj: Advancing Neuroendocrine Tumor Care in East and Sub-Saharan Africa
Opinion
Aug 10, 2025, 13:44
Olivier Elemento: Accelerating Innovation with Safe and Effective Guardrails
Voices
Aug 10, 2025, 13:01
Olubukola Ayodele: Breast Cancer Subtypes and What They Mean for Patients and Treatment
Voices
Aug 10, 2025, 12:49
Krishna Soujanya Gunturu: The Hartford HealthCare Cancer Institute Has Launched First-in-Human Phase 1A Clinical Trial
Blog
Aug 10, 2025, 12:46
Ashwin Mallya: Bladder Cancer Care is No Longer a Solo Act